{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:38:32Z","timestamp":1761100712662},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2004,10,18]],"date-time":"2004-10-18T00:00:00Z","timestamp":1098057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,10,18]],"date-time":"2004-10-18T00:00:00Z","timestamp":1098057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2004,12,1]]},"DOI":"10.1038\/sj.bmt.1704690","type":"journal-article","created":{"date-parts":[[2004,10,18]],"date-time":"2004-10-18T08:53:32Z","timestamp":1098089612000},"page":"987-994","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease"],"prefix":"10.1038","volume":"34","author":[{"given":"V T","family":"Ho","sequence":"first","affiliation":[]},{"given":"H T","family":"Kim","sequence":"additional","affiliation":[]},{"given":"S","family":"Li","sequence":"additional","affiliation":[]},{"given":"E P","family":"Hochberg","sequence":"additional","affiliation":[]},{"given":"C","family":"Cutler","sequence":"additional","affiliation":[]},{"given":"S J","family":"Lee","sequence":"additional","affiliation":[]},{"given":"D C","family":"Fisher","sequence":"additional","affiliation":[]},{"given":"E","family":"Milford","sequence":"additional","affiliation":[]},{"given":"G","family":"Kao","sequence":"additional","affiliation":[]},{"given":"H","family":"Daley","sequence":"additional","affiliation":[]},{"given":"J","family":"Levin","sequence":"additional","affiliation":[]},{"given":"A","family":"Ng","sequence":"additional","affiliation":[]},{"given":"P","family":"Mauch","sequence":"additional","affiliation":[]},{"given":"E P","family":"Alyea","sequence":"additional","affiliation":[]},{"given":"J H","family":"Antin","sequence":"additional","affiliation":[]},{"given":"R J","family":"Soiffer","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2004,10,18]]},"reference":[{"key":"BF1704690_CR1","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1182\/blood.V98.12.3192","volume":"98","author":"VT Ho","year":"2001","unstructured":"Ho VT, Soiffer RJ . The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood 2001; 98: 3192\u20133204.","journal-title":"Blood"},{"key":"BF1704690_CR2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1182\/blood.V72.2.520.520","volume":"72","author":"MM Zutter","year":"1988","unstructured":"Zutter MM, Martin PJ, Sale GE et al. Epstein\u2013Barr virus lymphoproliferation after bone marrow transplantation. Blood 1988; 72: 520\u2013529.","journal-title":"Blood"},{"key":"BF1704690_CR3","doi-asserted-by":"publisher","first-page":"806","DOI":"10.7326\/0003-4819-108-6-806","volume":"108","author":"JM Goldman","year":"1988","unstructured":"Goldman JM, Gale RP, Horowitz MM et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. Ann Intern Med 1988; 108: 806\u2013814.","journal-title":"Ann Intern Med"},{"key":"BF1704690_CR4","first-page":"377","volume":"18","author":"EJ Gerritsen","year":"1996","unstructured":"Gerritsen EJ, Stam ED, Hermans J et al. Risk factors for developing EBV-related B cell lymphoproliferative disorders (BLPD) after non-HLA-identical BMT in children. Bone Marrow Transplant 1996; 18: 377\u2013382.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704690_CR5","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1182\/blood.V74.6.2227.2227","volume":"74","author":"NA Kernan","year":"1989","unstructured":"Kernan NA, Bordignon C, Heller G et al. Graft failure after T-cell-depleted leukocyte antigen identical marrow transplants for leukemia: I. analysis of risk factors and results of secondary transplants. Blood 1989; 74: 2227\u20132236.","journal-title":"Blood"},{"key":"BF1704690_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.7326\/0003-4819-105-1-20","volume":"105","author":"RT Mitsuyasu","year":"1986","unstructured":"Mitsuyasu RT, Champlin RE, Gale RP et al. Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trial. Ann Intern Med 1986; 105: 20\u201326.","journal-title":"Ann Intern Med"},{"key":"BF1704690_CR7","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1182\/blood.V78.8.2120.2120","volume":"78","author":"A Marmont","year":"1991","unstructured":"Marmont A, Horowitz MM, Gale RP et al. T-cell depletion of HLA-identical transplants in leukemia. Blood 1991; 78: 2120\u20132130.","journal-title":"Blood"},{"key":"BF1704690_CR8","first-page":"3996","volume":"95","author":"RE Champlin","year":"2000","unstructured":"Champlin RE, Passweg JR, Zhang MJ et al. T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood 2000; 95: 3996\u20134003.","journal-title":"Blood"},{"key":"BF1704690_CR9","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood.V86.11.4337.bloodjournal86114337","volume":"86","author":"S Giralt","year":"1995","unstructured":"Giralt S, Hester J, Huh Y et al. CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. Blood 1995; 86: 4337\u20134343.","journal-title":"Blood"},{"key":"BF1704690_CR10","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood.V91.10.3671","volume":"91","author":"EP Alyea","year":"1998","unstructured":"Alyea EP, Soiffer RJ, Canning C et al. Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant. Blood 1998; 91: 3671\u20133680.","journal-title":"Blood"},{"key":"BF1704690_CR11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1053\/bbmt.2002.v8.abbmt080625","volume":"8","author":"RJ Soiffer","year":"2002","unstructured":"Soiffer RJ, Alyea EP, Hochberg E et al. Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion. Biol Blood Marrow Transplant 2002; 8: 625\u2013632.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1704690_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/00007890-199401000-00015","volume":"57","author":"SD Nimer","year":"1994","unstructured":"Nimer SD, Giorgi J, Gajewski JL et al. Selective depletion of CD8+ cells for prevention of graft-versus-host disease after bone marrow transplantation. A randomized controlled trial. Transplantation 1994; 57: 82\u201387.","journal-title":"Transplantation"},{"key":"BF1704690_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1056\/NEJM200101183440303","volume":"344","author":"WI Bensinger","year":"2001","unstructured":"Bensinger WI, Martin PJ, Storer B et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001; 344: 175\u2013181.","journal-title":"N Engl J Med"},{"key":"BF1704690_CR14","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/sj.bmt.1701234","volume":"21","author":"N Schmitz","year":"1998","unstructured":"Schmitz N, Bacigalupo A, Hasenclever D et al. Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1998; 21: 995\u20131003.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704690_CR15","first-page":"3702","volume":"95","author":"RE Champlin","year":"2000","unstructured":"Champlin RE, Schmitz N, Horowitz MM et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). Blood 2000; 95: 3702\u20133709.","journal-title":"Blood"},{"key":"BF1704690_CR16","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1200\/JCO.2001.19.16.3685","volume":"19","author":"C Cutler","year":"2001","unstructured":"Cutler C, Giri S, Jeyapalan S et al. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. J Clin Oncol 2001; 19: 3685\u20133691.","journal-title":"J Clin Oncol"},{"key":"BF1704690_CR17","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/aos\/1176350951","volume":"16","author":"R Gray","year":"1988","unstructured":"Gray R . A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Statist 1988; 16: 1141\u20131154.","journal-title":"Ann Statist"},{"key":"BF1704690_CR18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"G Kaplan","year":"1958","unstructured":"Kaplan G, Meier P . Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457\u2013481.","journal-title":"J Am Stat Assoc"},{"key":"BF1704690_CR19","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1182\/blood.V87.9.3984.bloodjournal8793984","volume":"87","author":"E Roux","year":"1996","unstructured":"Roux E, Helg C, Dumont-Girard F et al. Analysis of T-cell repopulation after allogeneic bone marrow transplantation: significant differences between recipients of T-cell depleted and unmanipulated grafts. Blood 1996; 87: 3984\u20133992.","journal-title":"Blood"},{"key":"BF1704690_CR20","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1182\/blood.V75.10.2076.2076","volume":"75","author":"RJ Soiffer","year":"1990","unstructured":"Soiffer RJ, Bosserman L, Murray C et al. Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation. Blood 1990; 75: 2076\u20132084.","journal-title":"Blood"},{"key":"BF1704690_CR21","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1182\/blood.V93.2.467","volume":"93","author":"TN Small","year":"1999","unstructured":"Small TN, Papadopoulos EB, Boulad F et al. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood 1999; 93: 467\u2013480.","journal-title":"Blood"},{"key":"BF1704690_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1083-8791(03)80110-6","volume":"9","author":"J Schwartz","year":"2003","unstructured":"Schwartz J, Buchbarker D, Griffin D et al. Single agent tacrolimus for prophylaxis of acute graft-versus host disease after related allogeneic peripheral blood stem cell transplantation: a phase II study. Biol Blood Marrow Transplant 2003; 9: 97 (abstr 109).","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1704690_CR23","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1084\/jem.178.2.703","volume":"178","author":"PJ Martin","year":"1993","unstructured":"Martin PJ . Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans. J Exp Med 1993; 178: 703\u2013712.","journal-title":"J Exp Med"},{"key":"BF1704690_CR24","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1182\/blood.V94.7.2192.419a38_2192_2199","volume":"94","author":"PJ Martin","year":"1999","unstructured":"Martin PJ, Rowley SD, Anasetti C et al. A phase I\u2013II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients. Blood 1999; 94: 2192\u20132199.","journal-title":"Blood"},{"key":"BF1704690_CR25","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1182\/blood.V78.11.3103.3103","volume":"78","author":"MF Bertheas","year":"1991","unstructured":"Bertheas MF, Lafage M, Levy P et al. Influence of mixed chimerism on the results of allogeneic bone marrow transplantation for leukemia. Blood 1991; 78: 3103\u20133106.","journal-title":"Blood"},{"key":"BF1704690_CR26","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1182\/blood.V83.11.3409.3409","volume":"83","author":"S Mackinnon","year":"1994","unstructured":"Mackinnon S, Barnett L, O'Reilly RJ . Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia. Blood 1994; 83: 3409\u20133416.","journal-title":"Blood"},{"key":"BF1704690_CR27","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/blood.V76.2.418.418","volume":"76","author":"R Champlin","year":"1990","unstructured":"Champlin R, Ho W, Gajewski J et al. Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation. Blood 1990; 76: 418\u2013423.","journal-title":"Blood"},{"key":"BF1704690_CR28","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1182\/blood.V98.4.934","volume":"98","author":"E Alyea","year":"2001","unstructured":"Alyea E, Weller E, Schlossman R et al. T cell depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft versus myeloma effect. Blood 2001; 98: 934\u2013939.","journal-title":"Blood"},{"key":"BF1704690_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1089\/152581602753658484","volume":"11","author":"F Baron","year":"2002","unstructured":"Baron F, Baudoux E, Frere P et al. Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cells. J Hematother Stem Cell Res 2002; 11: 301\u2013314.","journal-title":"J Hematother Stem Cell Res"},{"key":"BF1704690_CR30","first-page":"271","volume":"15","author":"J Jansen","year":"1995","unstructured":"Jansen J, Hanks S, Akard L et al. Selective T cell depletion with CD8-conjugated magnetic beads in the prevention of graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 15: 271\u2013278.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704690_CR31","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.1182\/blood-2003-04-1320","volume":"102","author":"L Cosmi","year":"2003","unstructured":"Cosmi L, Liotta F, Lazzeri E et al. Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood 2003; 102: 4107\u20134114.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1704690","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704690.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704690.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:14:08Z","timestamp":1648077248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1704690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,18]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,12,1]]}},"alternative-id":["BF1704690"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1704690","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10,18]]},"assertion":[{"value":"27 April 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}